September 13, 2021 -- Contract development and manufacturing organization Samsung Biologics has signed a memorandum of understanding to join the Frontier 1.5D initiative, which will develop a climate risk management model as part of South Korea's 2050 Carbon Neutral Strategy.
Frontier 1.5D is an effort to limit global temperature rise to 1.5 degrees Celsius above preindustrial levels. Samsung plans to monitor its biopharmaceutical manufacturing plants through an initiative it calls the Carbon Disclosure Project, the company said.